Last updated on December 2018

EMPagliflozin outcomE tRial in Patients With chrOnic heaRt Failure With Reduced Ejection Fraction (EMPEROR-Reduced)


Brief description of study

The aim of the study is to investigate the safety and efficacy of empagliflozin versus placebo on top of guideline-directed medical therapy in patients with heart failure with reduced ejection fraction.

Clinical Study Identifier: NCT03057977

Contact Investigators or Research Sites near you

Start Over

Hareaki Yamamoto

Yamamoto Clinic
Kanagawa, Sagamihara, Japan
2.69miles
  Connect »

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.